Table 2.

Carriers described in the IMPDs.

Code	Description	Term in IMPD	Pharmaceutical Form	Study Phase	Therapeutic Area	Active Substance of Chemical Origin?	Active Substance of Biological/Biotechnological Origin?	Gene Therapy Medicinal Product?
C1	Human serum albumin (HSA)	Carrier protein	Solution for infusion	II	Eye diseases	No	Yes	No
C2	Keyhole limpet hemocyanin (KLH) subunits	Carrier protein	Suspension for injection	II	Nervous system diseases	No	Yes	No
C3	Red blood cells (RBC)	Carrier	Solution for infusion	III	Cancer	No	Yes	No
C4	Non-toxic mutant of diphtheria toxin (CRM197)	Carrier	Suspension for injection	III	Bacterial infections and mycoses	No	Yes	No
C5	mPEG succinimide	Carrier	Powder and solvent for solution for injection	II	Hormonal diseases	No	Yes	No
C6	Tetanus toxoid protein	Carrier protein	Solution for injection	III	Bacterial infections and mycoses	No	Yes	No
C7	Lactose α-monohydrate	Carrier	Inhalation powder	III	Respiratory tract diseases	Yes	No	No
C8	Copovidone	Carrier polymer	Coated tablet	III	Cancer	Yes	No	No
C9	Sugar spheres	Carrier	Capsules	III	Immune system diseases	Yes	No	No
C10	Vitamin E polyethylene glycol succinate	Carrier	Capsules	II	Cancer	Yes	No	No